AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06154590 — intervention group
Intervention type: DRUG
Intervention: Method(s)1 Attribution
Description: Intervention(s): Attribution defines the relationship between the adverse event and the investigational agent(s)/intervention. Assign the appropriate category code of attribution Codes: 1-5, Descriptor, Unrelated, Unlikely, Possible, Probable, Definite.~Definitions: Use the Adverse Event Dose Units- Indicate the dosing units (e.g., mg) administered to the patient. TAC, Reporting Group: Participants with Disease, Description: Presence of Disease as Defined by positive reference test.~Dosage Form: 1mg Anastrozole, given once daily. 20 mg NOLVADEX (tamoxifen citrate) tablet given once daily, (the 20 mg NOLVADEX (tamoxifen citrate) tablet is bioequivalent to the 10 mg NOLVADEX. (tamoxifen citrate) tablets.)
Study NCT06154590 — intervention group
Intervention type: DRUG
Intervention: Method(s)2 Attribution,
Description: Intervention(s): -Attribution defines the relationship between the adverse event and the investigational agent(s)/intervention. Assign the appropriate category code of attribution Codes: 1-5, Descriptor, Unrelated, Unlikely, Possible, Probable, Definite.~Definitions: Use Adverse Events. Dose Units- Indicate the dosing units (e.g., mg) administered to the patient TAC. Reporting Group: Participant without Disease, Description: Absence of Disease as defined by negative reference test.~Dosage Form: 1mg Anastrozole, given once daily. 20 mg NOLVADEX (tamoxifen citrate) tablet given once daily, (the 20 mg NOLVADEX (tamoxifen citrate) tablet is bioequivalent to the 10 mg NOLVADEX. (tamoxifen citrate) tablets.)
Study NCT05112640 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: INSORB: subcuticular stapling device
Description: Under the skin stapling device that delivers absorbable staples
Study NCT05112640 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Subcuticular monocryl suture manufactured by Ethicon
Description: Under the skin suture placed by hand
Study NCT04849897 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental: Virtual Reality Guided Imagery
Description: Platform and VR Goggles
Study NCT04849897 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator: Audio Only Guided Imagery
Description: Audio Recordings of Guided Imagery via an iPAD
Study NCT04845841 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elinzanetant (BAY3427080) treatment A
Description: Single oral dose
Study NCT04845841 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elinzanetant (BAY3427080) treatment B
Description: Single oral dose
Study NCT05637476 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional strength training of hip abductors
Description: Every participant will perform three sets of fifteen repetitions, fifteen seconds rest in between, three times per week for the following exercises:~1. Pelvic drop.~2. Single leg -bridge.~3. Side-lying hip abduction with hip internal rotation.~4. Lateral step-up.~5. Standing hip abduction on stance or swing leg with extra resistance .
Study NCT05637476 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: A selected physical therapy exercise program
Description: Every participant will perform three sets of fifteen repetitions, fifteen seconds rest in between, three times per week for the following exercises:~1. Strength dorsiflexors of the ankle-using rubber band.~2. Eccentric calf exercise (calf raise) .~3. Balance and proprioceptive exercise using wobble boards.~4. Stretch planter flexors (three sets of thirty repetitions, thirty seconds rest in between, three times per week)
Study NCT05637476 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: A selected physical therapy exercise program
Description: Every participant will perform three sets of fifteen repetitions, fifteen seconds rest in between, three times per week for the following exercises:~1. Strength dorsiflexors of the ankle-using rubber band.~2. Eccentric calf exercise (calf raise) .~3. Balance and proprioceptive exercise using wobble boards.~4. Stretch planter flexors (three sets of thirty repetitions, thirty seconds rest in between, three times per week)
Study NCT05499234 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dolantin
Description: If VAS score is more than 4 even after additional dose, use dolantin 1 mg/kg
Study NCT05499234 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paracetamol
Description: If VAS score is more than 4 even after dolantin 1 mg/kg, 10 mg/kg paracetamol IV
Study NCT05848401 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biosound Therapy System
Description: Biosound Therapy consists of biofeedback, vibroacoustic therapy synchronized with music that plays binaural beats, and video content.
Study NCT04969874 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Remote follow-up
Description: The feeling of swallowing will be assessed at the end of the stay at the rehabilitation center, which corresponds to the first visit, and then every month for 5 months during remote interviews and on discharge with the Deglutition Handicap Index (DHI), a self-assessment questionnaire for the swallowing handicap.~The quality of life will be assessed at the firs visit and 6 months after using the EORTC QLQ 30 quality of life scale and the H\&N annex, a self-assessment questionnaire on the quality of life for people with cancer of the head and neck.~The satisfaction of users and the interest of city health professionals in the use of the MAX Educ tool as part of a monthly monitoring will be collected via the TUQ questionnaire, through the MAX platform at Month 6.
Study NCT06293547 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Silver Diamine Fluoride
Description: Silber Diamine Fluoride, a colorless, odorless alkaline solution, effectively halts carious lesions in various populations, including children and elderly patients, or those averse to invasive treatments. Its high fluoride content facilitates remineralization, caries arrest, and prevention. SDF application is simple, non-invasive, cost-effective, and does not stain intact enamel, making it suitable for treating dentin hypersensitivity. Its ease of use is advantageous for children, patients with special needs, and the elderly. Particularly beneficial for high-risk patients with salivary dysfunction or multiple carious lesions, SDF offers potential in pediatric dentistry and community oral health by streamlining procedures, requiring rapid application without sharp instruments or anesthesia.
Study NCT04450953 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Eplerenone 50mg/day (cross over design)
Description: Eplerenone 50mg/day for 6 months followed
Study NCT04450953 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Period without eplerenone (cross over design)
Description: 6-month period without eplerenone
Study NCT05532800 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JS002
Description: JS002:150mg(1mL) Q2W PFS, Placebo: 1mL Q2W PFS.
Study NCT05532800 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: JS002:150mg(1mL) Q2W AI, Placebo: 1mL Q2W AI.
Study NCT04975243 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GentleMax Pro Plus 755nm and 1064nm laser system
Description: The GentleMax Pro Plus is a 755nm and 1064nm laser system. The GentleMax Pro PlusTM is indicated for stable long-term or permanent hair reduction using varying spot sizes and fluences.
Study NCT05644652 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: designed physical therapy program
Description: it will be applied for for 60 min weekly for 3 successive months in the form of three sets of exercises (20 minutes each) as follows:~* Flexibility exercises to restore joint mobility of soft tissues.~* Static and dynamic balance exercises~* Functional strengthening exercises.~* Functional gait training.
Study NCT05644652 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nordic walking
Description: it will be conducted according to the guidelines of the International Nordic Walking Federation
Study NCT05283044 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: biopsy liquid
Description: Patient performs a blood test at treatment baseline
Study NCT04905381 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: This arm receives usual care (control group)
Study NCT06353308 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sexual Violence Prevention
Description: The intervention included a game, five short videos, two posters, and five online quizzes, which were provided with a frequency of two posts per week and a final real-time online workshop. Materials included content on the spectrum of gender and sexual identities and orientations, gender and sexual roles, consent and communication, body positivity and self-acceptance, sexual pleasure and desire, as well as risky sexual behavior associated with dating app use and the legal issues and risks of sexual assault, such as precautionary steps and available resources.
Study NCT06353308 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Sexual health intervention
Description: This general online sexual health education consisted of online videos, quizzes and game that covered a wide range of diverse topics on love, sex and relationships such as healthy and respectful relationships, body self-esteem, sexual identity and orientation, sexual rights and decision making, in addition to the conventional focus on sexual dysfunction and disease aversion.
Study NCT05996692 — intervention group
Intervention type: OTHER
Intervention: Evaluation of adherence to walking prescriptions
Description: Adherence to walking prescriptions was evaluated according to a specific criterion (walking at least 30 min, in bouts of 15 min, with a small rest between bouts, twice a week, over a minimum of six consecutive weeks) based on previous recommendations.
Study NCT05507996 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant adeno-associated virus administration
Description: The investigational medical product will be injected from 1E12 GC/kg to 1E14 GC/kg.
Study NCT05504434 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Single-use gastroscope
Description: Adults patients are treated with a single use gastroscope instead of a reusable gastroscope
Study NCT04905381 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LENA Star Program sessions
Description: LENA Start is an evidence-based community program designed to engage families and help them learn how to increase conversation with their children during the first few years of life.
Study NCT04835129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isatuximab (for run-in portion)
Description: 10 mg/kg IV on days 2, 8, 15, 22 of cycle 2 and days 1 and 15 of subsequent cycles.
Study NCT04835129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isatuximab (for expansion)
Description: 10 mg/kg IV on days 2, 8, 15, 22 of cycle 1 and days 1 and 15 of subsequent cycles.
Study NCT04835129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: 4 mg PO days 1-21 of each cycle.
Study NCT04835129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elotuzumab
Description: 10 mg/kg on days 1, 8, 15, 22 of cycles 1 and 2; 20 mg/kg on day 1 of subsequent cycles.
Study NCT04689269 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The simulated easy airway
Description: A high-fidelity simulator (Airway Management Trainer, model AA-3100, Laerdal Medical Ltd., Orpington, England, UK) will be equipped to create an easy airway situation by adjusting the manikin until it becomes in a neutral position
Study NCT04689269 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The simulated difficult airway
Description: A high-fidelity simulator (Airway Management Trainer, model AA-3100, Laerdal Medical Ltd., Orpington, England, UK) will be equipped to create a difficult airway scenario will be established by placing the occiput on an Oasis Elite™ Prone Head Rest, Adult (140 mm in height) (Covidien, Mansfield, MA, USA), and inhibiting head and neck movement by securing the head with an adhesive tape, simulating the effect produced by a cervical-collar.
Study NCT04689269 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: King Vision Laryngoscope
Description: Using a King Vision Laryngoscope for placement of the DLT
Study NCT04689269 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MacGrath Laryngoscope
Description: Using a MacGrath Laryngoscope for placement of the DLT
Study NCT06540027 — intervention group
Intervention type: PROCEDURE
Intervention: rectal cacer surgery
Description: minimally invasive surgery
Study NCT05514418 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intensive Adherence Counselling (IAC)
Description: Intensive adherence counselling is offered to people living with HIV (PLHIV) having a non-suppressed viral load (VL) result ( a VL of 1,000 copies/ml or more) and this is given once every month for three months. In our study, we are going to give IAC to PLHIV with low-level viraemia (having a VL of 50 copies/ml but less than 1,000 copies/ml) and determine its effectiveness in causing a non-detectable VL (less than 50 copies/ml), which is desirable for PLHIV on ART.
Study NCT05763693 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azithromycin at Baseline
Description: this group will be randomized to receive a single oral dose of azithromycin (20mg/kg) at baseline
Study NCT05763693 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azithromycin at Day 21
Description: this group will be randomized to receive a single oral dose of azithromycin (20mg/kg) at the day 21 visit
Study NCT05763693 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo at Baseline
Description: this group will be randomized to receive Placebo at baseline
Study NCT05763693 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo at Baseline
Description: this group will be randomized to receive Placebo at baseline
Study NCT05763693 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo at Day 21
Description: This group will be randomized to receive Placebo at the day 21 visit
Study NCT05763693 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo at Day 21
Description: This group will be randomized to receive Placebo at the day 21 visit
Study NCT03959631 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Communities of practice
Description: based on a web 2.0 platform in which there is interaction with other patients and with a multidisciplinary team of professionals. The intervention will be co-designed with a group of patients and a group of primary and specialized care professionals.
Study NCT04835129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: 40 mg (20 mg if >75 years) PO or IV on days 1, 8,15 and 22 of each cycle.
Study NCT05116215 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydrogen
Description: Hydrogen supplement
Study NCT05167929 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-determination Enhancement Group
Description: The self-determination enhancement group - Each group has eight participants. There will be 10 sessions per group and each session will last 1.5 hours.
Study NCT05167929 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-determination Enhancement Plus Group
Description: The self-determination enhancement PLUS group - Each group has eight participants and their caregivers. There will be 10 sessions per group and each session will last 1.5 hours. Meanwhile, their caregivers will attend four sessions separately and each session will last 1.5 hours.
Study NCT05167929 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Leisure activity group
Description: Leisure activity group - Leisure activity group is the comparison group. Each group will consist of eight adults with mild intellectual disability. There will be 10 sessions for the group and each session will last for 1.5 hours.
Study NCT04937478 — intervention group
Intervention type: OTHER
Intervention: Observation
Description: Only observational study, no intervention.
Study NCT04823130 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dupilumab (SAR231893)
Description: Pharmaceutical form: solution for injection Route of administration: subcutaneous
Study NCT05389709 — intervention group
Intervention type: DRUG
Intervention: Iberogast (STW5-II, BAY98-7410)
Description: Survey without any intervention assigned in the study.
Study NCT06553144 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: control
Description: Canals were irrigated with only10 mL of 5% NaOCl
Study NCT06553144 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: methylene blue
Description: 0.1 mg/mL methylene blue solition delivered into the canal and irradiated with a 100mW diode laser at a wavelength of 660 nm
Study NCT06553144 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: erythrosine b
Description: 0.3 mg/mL eryrhtosine b solition delivered into the canal and irradiated with a 100mW diode laser at a wavelength of 660 nm
Study NCT06553144 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: curcumin
Description: 5.0 mg/mL curcumin solition delivered into the canal and irradiated with a 200mW diode laser at a wavelength of 450 nm
Study NCT06492785 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: High Hyaluronic Acid concentrations (0.5 mg/ml)
Description: Hyaluronic Acid(EmbryoGlue®)
Study NCT06492785 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Low Hyaluronic Acid concentrations (0.125 mg/ml)
Description: Hyaluronic Acid (G2 medium)
Study NCT06381258 — intervention group
Intervention type: PROCEDURE
Intervention: Ultrasound
Description: Fetal echocardiography using ultrasound device
Study NCT05836818 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Question (Q)
Description: Flu vaccine acceptance question: a question asked of participants about their willingness to accept a flu vaccine
Study NCT05332054 — intervention group
Intervention type: BIOLOGICAL
Intervention: Allogeneic CAR-T therapy
Description: N/A this is an observational study
Study NCT06449755 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Radiologic examination
Description: Posoperative first week, month and third month On the x-ray of Hand AP view: metacarpal shortening On the x-ray of Hand 30 degree pronation view: dorsal angulation
Study NCT06449755 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Grip Strength
Description: Postoperative first month and third month grip streng compare with Cambry hand dinamometer.
Study NCT05408780 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AC-OLE-01-VA
Description: formulation of tricaprilin or matching placebo
Study NCT05086926 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Exercises and CSI
Description: Corticosteroid injection:~The project manager will give the participants one injection with cortisone and lidocaine in the lateral hip at baseline. The procedure will be performed aseptically.~Home exercise program:~The exercise programis based on previous literature and expert opinions that has been synthesized in a Delphi study conducted by our research group. The exercise program consists of three body weighted strength exercises, that are to be performed every second day for a period of 8 weeks. Exercise instructions will be available as a handout and online with video instructions. The corticosteroid injection usually causes a flare-up in pain with a duration of up to 48 hours. Participants will be instructed to begin the exercises as soon as possible after this flare-up has settled.
Study NCT05836818 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Messaging (M)
Description: Flu vaccine educational materials -videos and flyers containing flu vaccine educational information
Study NCT06268106 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Graphic novel visualization
Description: Patients in interventional group do receive and visualize graphic novel, which is more informative than standard informed consent.
Study NCT05707260 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CKD SMS
Description: The intervention begins with a face-to-face or digitally assisted session, entry into improving the knowledge and self-management of CKD through, using the four sources of manipulation of self-efficacy (achievement of performance, indirect experience, verbal persuasion, and self-evaluation). In this session, participants will be asked to identify their problems related to CKD and establish, based on these two goals, that they are real and achievable according to their priorities. These goals will be recorded in the monitoring format and will be monitored in the telephone or WhatsApp follow-ups. This using the performance achievement manipulation source, said session lasts 60 minutes, as does the final session at week 16.
Study NCT05140785 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Advanced MRI sequences
Description: Advanced MRI sequences which look to a) determine structure of a primary brain tumour and b) metabolism within a primary brain tumour
Study NCT04932993 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Writing down goals
Description: Patient will write their health goals down before the visit.
Study NCT06277596 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Clinical Pilates exercises (basic and advanced stabilization exercises)
Study NCT06277596 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Clinical Pilates exercises (basic and advanced stabilization exercises)
Study NCT06166485 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: take a bath
Description: The effects of two different bathtub bath methods on physiological parameters will be compared in babies divided into 2 different groups.